EGM
DYN icon

Engineers Gate Manager’s Dyne Therapeutics DYN Stock Holding History

Engineers Gate Manager’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,420
Closed -$443K – 2329
2026
Q1 		$443K Buy
24,420
+2,801
+13% +$48.3K 0.01% 1478
2025
Q4 		$423K Sell
21,619
-81,372
-79% -$1.54M 0.01% 1446
2025
Q3 		$1.3M Sell
102,991
-69,478
-40% -$792K 0.01% 1012
2025
Q2 		$1.64M Buy
172,469
+87,551
+103% +$964K 0.02% 842
2025
Q1 		$888K Buy
+84,918
New +$1.21M 0.02% 1131
2024
Q4 		– Sell
-9,776
Closed -$351K – 2306
2024
Q3 		$351K Buy
+9,776
New +$389K 0.01% 1555

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Engineers Gate Manager's DYN Position: Q2 2026 in Review

Engineers Gate Manager sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 24,420 shares — an estimated $443K sold.

Engineers Gate Manager first reported a position in DYN in Q3 2024 and held it in 6 quarters. The position peaked at $1.64M in Q2 2025. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Engineers Gate Manager reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 24,420 Dyne Therapeutics shares in Q2 2026, an estimated $443K.
  • Engineers Gate Manager first reported a position in Dyne Therapeutics in Q3 2024 and held it in 6 quarters.
  • Engineers Gate Manager's Dyne Therapeutics position peaked at $1.64M in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.